BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 31722744)

  • 1. BRM: the core ATPase subunit of SWI/SNF chromatin-remodelling complex-a tumour suppressor or tumour-promoting factor?
    Jancewicz I; Siedlecki JA; Sarnowski TJ; Sarnowska E
    Epigenetics Chromatin; 2019 Nov; 12(1):68. PubMed ID: 31722744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Striking phenotypic overlap between Nicolaides-Baraitser and Coffin-Siris syndromes in monozygotic twins with ARID1B intragenic deletion.
    Pascolini G; Valiante M; Bottillo I; Laino L; Fleischer N; Ferraris A; Grammatico P
    Eur J Med Genet; 2020 Mar; 63(3):103739. PubMed ID: 31421289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
    Schallenberg S; Bork J; Essakly A; Alakus H; Buettner R; Hillmer AM; Bruns C; Schroeder W; Zander T; Loeser H; Gebauer F; Quaas A
    BMC Cancer; 2020 Jan; 20(1):12. PubMed ID: 31906887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.
    Karnezis AN; Wang Y; Ramos P; Hendricks WP; Oliva E; D'Angelo E; Prat J; Nucci MR; Nielsen TO; Chow C; Leung S; Kommoss F; Kommoss S; Silva A; Ronnett BM; Rabban JT; Bowtell DD; Weissman BE; Trent JM; Gilks CB; Huntsman DG
    J Pathol; 2016 Feb; 238(3):389-400. PubMed ID: 26356327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive molecular study on Coffin-Siris and Nicolaides-Baraitser syndromes identifies a broad molecular and clinical spectrum converging on altered chromatin remodeling.
    Wieczorek D; Bögershausen N; Beleggia F; Steiner-Haldenstätt S; Pohl E; Li Y; Milz E; Martin M; Thiele H; Altmüller J; Alanay Y; Kayserili H; Klein-Hitpass L; Böhringer S; Wollstein A; Albrecht B; Boduroglu K; Caliebe A; Chrzanowska K; Cogulu O; Cristofoli F; Czeschik JC; Devriendt K; Dotti MT; Elcioglu N; Gener B; Goecke TO; Krajewska-Walasek M; Guillén-Navarro E; Hayek J; Houge G; Kilic E; Simsek-Kiper PÖ; López-González V; Kuechler A; Lyonnet S; Mari F; Marozza A; Mathieu Dramard M; Mikat B; Morin G; Morice-Picard F; Ozkinay F; Rauch A; Renieri A; Tinschert S; Utine GE; Vilain C; Vivarelli R; Zweier C; Nürnberg P; Rahmann S; Vermeesch J; Lüdecke HJ; Zeschnigk M; Wollnik B
    Hum Mol Genet; 2013 Dec; 22(25):5121-35. PubMed ID: 23906836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygous missense mutations in SMARCA2 cause Nicolaides-Baraitser syndrome.
    Van Houdt JK; Nowakowska BA; Sousa SB; van Schaik BD; Seuntjens E; Avonce N; Sifrim A; Abdul-Rahman OA; van den Boogaard MJ; Bottani A; Castori M; Cormier-Daire V; Deardorff MA; Filges I; Fryer A; Fryns JP; Gana S; Garavelli L; Gillessen-Kaesbach G; Hall BD; Horn D; Huylebroeck D; Klapecki J; Krajewska-Walasek M; Kuechler A; Lines MA; Maas S; Macdermot KD; McKee S; Magee A; de Man SA; Moreau Y; Morice-Picard F; Obersztyn E; Pilch J; Rosser E; Shannon N; Stolte-Dijkstra I; Van Dijck P; Vilain C; Vogels A; Wakeling E; Wieczorek D; Wilson L; Zuffardi O; van Kampen AH; Devriendt K; Hennekam R; Vermeesch JR
    Nat Genet; 2012 Feb; 44(4):445-9, S1. PubMed ID: 22366787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical correlations of mutations affecting six components of the SWI/SNF complex: detailed description of 21 patients and a review of the literature.
    Kosho T; Okamoto N; Ohashi H; Tsurusaki Y; Imai Y; Hibi-Ko Y; Kawame H; Homma T; Tanabe S; Kato M; Hiraki Y; Yamagata T; Yano S; Sakazume S; Ishii T; Nagai T; Ohta T; Niikawa N; Mizuno S; Kaname T; Naritomi K; Narumi Y; Wakui K; Fukushima Y; Miyatake S; Mizuguchi T; Saitsu H; Miyake N; Matsumoto N
    Am J Med Genet A; 2013 Jun; 161A(6):1221-37. PubMed ID: 23637025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterozygous Mutations in SMARCA2 Reprogram the Enhancer Landscape by Global Retargeting of SMARCA4.
    Gao F; Elliott NJ; Ho J; Sharp A; Shokhirev MN; Hargreaves DC
    Mol Cell; 2019 Sep; 75(5):891-904.e7. PubMed ID: 31375262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SWI/SNF complex in disorder: SWItching from malignancies to intellectual disability.
    Santen GW; Kriek M; van Attikum H
    Epigenetics; 2012 Nov; 7(11):1219-24. PubMed ID: 23010866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers.
    Papillon JPN; Nakajima K; Adair CD; Hempel J; Jouk AO; Karki RG; Mathieu S; Möbitz H; Ntaganda R; Smith T; Visser M; Hill SE; Hurtado FK; Chenail G; Bhang HC; Bric A; Xiang K; Bushold G; Gilbert T; Vattay A; Dooley J; Costa EA; Park I; Li A; Farley D; Lounkine E; Yue QK; Xie X; Zhu X; Kulathila R; King D; Hu T; Vulic K; Cantwell J; Luu C; Jagani Z
    J Med Chem; 2018 Nov; 61(22):10155-10172. PubMed ID: 30339381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confirmation of an ARID2 defect in SWI/SNF-related intellectual disability.
    Van Paemel R; De Bruyne P; van der Straaten S; D'hondt M; Fränkel U; Dheedene A; Menten B; Callewaert B
    Am J Med Genet A; 2017 Nov; 173(11):3104-3108. PubMed ID: 28884947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SWI/SNF subunit BRG1 affects alternative splicing by changing RNA binding factor interactions with nascent RNA.
    Gañez-Zapater A; Mackowiak SD; Guo Y; Tarbier M; Jordán-Pla A; Friedländer MR; Visa N; Östlund Farrants AK
    Mol Genet Genomics; 2022 Mar; 297(2):463-484. PubMed ID: 35187582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits.
    Raab JR; Runge JS; Spear CC; Magnuson T
    Epigenetics Chromatin; 2017 Dec; 10(1):62. PubMed ID: 29273066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SWI/SNF Complex: A Frequently Mutated Chromatin Remodeling Complex in Cancer.
    Nguyen VT; Tessema M; Weissman BE
    Cancer Treat Res; 2023; 190():211-244. PubMed ID: 38113003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Drosophila Brahma (SWI/SNF) chromatin remodeling complex exhibits cell-type specific activation and repression functions.
    Marenda DR; Zraly CB; Dingwall AK
    Dev Biol; 2004 Mar; 267(2):279-93. PubMed ID: 15013794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into DNA methylation signatures: SMARCA2 variants in Nicolaides-Baraitser syndrome.
    Chater-Diehl E; Ejaz R; Cytrynbaum C; Siu MT; Turinsky A; Choufani S; Goodman SJ; Abdul-Rahman O; Bedford M; Dorrani N; Engleman K; Flores-Daboub J; Genevieve D; Mendoza-Londono R; Meschino W; Perrin L; Safina N; Townshend S; Scherer SW; Anagnostou E; Piton A; Deardorff M; Brudno M; Chitayat D; Weksberg R
    BMC Med Genomics; 2019 Jul; 12(1):105. PubMed ID: 31288860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced adenoid cystic carcinoma (ACC) is featured by SWI/SNF chromatin remodeling complex aberrations.
    Jagielska B; Sarnowska E; Rusetska N; Jancewicz I; Durzynska M; Kubala S; Chmielik E; Paul P; Rutkowski T; Sarnowski TJ; Siedlecki JA
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):201-211. PubMed ID: 30382367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers.
    Hoffman GR; Rahal R; Buxton F; Xiang K; McAllister G; Frias E; Bagdasarian L; Huber J; Lindeman A; Chen D; Romero R; Ramadan N; Phadke T; Haas K; Jaskelioff M; Wilson BG; Meyer MJ; Saenz-Vash V; Zhai H; Myer VE; Porter JA; Keen N; McLaughlin ME; Mickanin C; Roberts CW; Stegmeier F; Jagani Z
    Proc Natl Acad Sci U S A; 2014 Feb; 111(8):3128-33. PubMed ID: 24520176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRM and BRG1 subunits of the SWI/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours.
    Bock VL; Lyons JG; Huang XX; Jones AM; McDonald LA; Scolyer RA; Moloney FJ; Barnetson RS; Halliday GM
    Br J Dermatol; 2011 Jun; 164(6):1221-7. PubMed ID: 21564052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy.
    Wanior M; Krämer A; Knapp S; Joerger AC
    Oncogene; 2021 May; 40(21):3637-3654. PubMed ID: 33941852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.